MedPath

A study to evaluate the effects of lactic acid bacteria on menstrual symptoms

Not Applicable
Conditions
Healthy volunteers
Registration Number
JPRN-UMIN000044933
Lead Sponsor
Soiken Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are pregnant or lactating, or intending to become pregnant during the study 2. Subjects who have histories of gynecologic disorder or have gynecologic disorder 3. Subjects with food allergies 4. Subjects who have diarrhea by intake of dairy products 5. Subjects who take regularly pharmaceuticals (including Chinese medicine and pill) or supplements which have the possibility to affect the results of the present study from 2 months before the time of informed consent to the day of informed consent 6. Subjects who take foods or drinks containing lactic acid bacteria (e.g. yoghurt) which have the possibility to affect the results of the present study 4 days or more a week 7. Subjects who had participated in other pharmaceutical or food clinical studies from 1 month before the time of informed consent to the day of informed consent 8. Subjects who often take analgesics for prophylactic purposes before having menstrual pain 9. Subjects whose MDQ score after menstruation is 1 or more points higher compared to the score of before or during menstruation at the first screening 10. Subjects with severe menstrual symptoms unable to be controlled by OTC analgesics 11. Subjects classified as psychosomatic (Type IV) by CMI health questionnaire 12. Subjects with a score of 20 or more for the stress score by Stress Check List 13. Subjects deemed unsuitable for the present study by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MDQ (Menstrual Distress Questionnaire) score
Secondary Outcome Measures
NameTimeMethod
VAS (Visual Analogue Scale) SF-36 (Medical Outcomes Study 36-Item Short-Form Health Survey) score Number of analgesic use
© Copyright 2025. All Rights Reserved by MedPath